Search for European Projects

7 European Projects Found

Searched on 125080 European Projects

 FINISHED 

Multisystem Cell Therapy for Improvement of Urinary Continence (MUSIC)

Start date: Jan 1, 2017, End date: Dec 31, 2021,

... with NMES and to further improve its feasibility and clinical efficacy. The ultimate goal is to significantly improve the patients` quality of life and to exploit a future commercial opportunity by expanding the know-how to various smaller RM centers and companies within Europe, thus, making personalized medicine using autologous cells a more feasible SUI treatment option."
Read Project

 5

 FINISHED 

Stem-cell based therapy for kidney repair (STELLAR)

Start date: Nov 1, 2012, End date: Oct 31, 2017,

Chronic kidney disease (CKD) affects 8% of the European population and ultimately results in renal failure due to progressive fibrosis. CDK carries a high mortality risk and the number of affected people rises, increasing the demand on renal replacement therapies while the number of available donor organs stays stable.The STELLAR consortium proposes to develop an alternative to renal replacement ...
Read Project

 15

 FINISHED 

Rapid Prototyping of Custom-Made Bone-Forming Tissue Engineering Constructs (RAPIDOS)

Start date: Jul 1, 2013, End date: Jun 30, 2017,

"In cranio-maxillofacial surgery, large blow-out orbital floor fractures have still mitigated outcomes and improved scaffold solutions are needed. The reconstruction of large bone defects in proximal femur or proximal tibia in orthopaedic surgery is also an enormous challenge due to the requirements for both complex shape and partial load bearing ability. This is the goal of this European and Chin ...
Read Project

 4

 FINISHED 

Growing bone fast and cost-effective (CHARME)

Start date: Jul 1, 2015, End date: Jun 30, 2017,

XPAND Biotechnology BV has developed a new generation of orthopaedic materials: the EpitaxOs bone regeneration material. EpitaxOs (TRL 6) is unique:a) it seduces the body to form boneb) is as effective as the golden standard autograft without its disadvantages (extra operative procedure, pain, limited quantity available)c) it is superior to other synthetic bone graft materials, allograft, growth f ...
Read Project

 1

 FINISHED 

bioREACtor for stem cell tHerapy (REACH)

Start date: Jul 1, 2013, End date: Jun 30, 2016,

The REACH-project is a direct result of the FP7 StemExpand project, which aimed at the expansion and engraftment of hematopoietic and mesenchymal stem cells (MSC) for clinical use. The results of these research activities show that a novel, closed and controlled bioreactor can be developed to grow clinically relevant numbers (>400 million) of MSCs. XPand Biotechnology BV(NL) [bioreactor developmen ...
Read Project

 4

 FINISHED 

Regenerating Bone defects using New biomedical Engineering approaches (REBORNE)

Start date: Jan 1, 2010, End date: Jun 30, 2015,

...boratories, SMEs manufacturing biomaterials, GMP-cell producing facilities and surgeons in hospitals as well as the consideration of ethical and regulatory issues. It is expected that REBORNE will expand the competitiveness of Europe through the patenting of new CE-marked bioproducts in the field of regenerative medicine.
Read Project

 24

 FINISHED 

Stem Cell Expansion - Expansion and engraftment of haematopoietic and mesenchymal stem cells (STEMEXPAND)

Start date: Nov 1, 2008, End date: Oct 31, 2011,

... stem cells will be defined and subsets of more primitive and more mature mesenchymal stem cells will be identified. Mesenchymal stem cells will also be used to improve engraftment efficiency of the expanded hematopoietic cells and to reduce the frequency of graft versus host disease. The findings are expected to have a great impact on the treatment of serious blood disorders by blood and marrow t ...
Read Project

 8